Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · IEX Real-Time Price · USD

3.770

+0.130 (3.57%)

At close: May 3, 2024, 4:00 PM

3.700

-0.070 (-1.86%)

After-hours: May 3, 2024, 7:09 PM EDT

Caribou Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	51.16	58.34	240.42	15.95	41.07
Short-Term Investments	277.67	189.33	135.41	0	8.4
Cash & Cash Equivalents	328.83	247.66	375.83	15.95	49.47
Cash Growth	32.77%	-34.10%	2255.87%	-67.75%	-
Receivables	2.43	2.42	6.64	5.16	3.98
Other Current Assets	7.58	10.17	8.72	3.19	3.56
Total Current Assets	338.84	260.25	391.19	24.31	57.01
Property, Plant & Equipment	40.45	34.91	4.89	3.5	4.33
Long-Term Investments	51.33	77.07	45.3	7.63	0
Other Long-Term Assets	1.59	1.54	0.98	0.61	0.59
Total Long-Term Assets	93.37	113.52	51.16	11.74	4.93
Total Assets	432.21	373.77	442.36	36.05	61.93
Accounts Payable	3.12	1.15	3.99	2.6	2.54
Deferred Revenue	8.95	25.89	30.74	1.1	1.7
Current Debt	1.2	0.97	0	0.65	0
Other Current Liabilities	15.03	0.13	-8.9	8.04	5.84
Total Current Liabilities	28.3	28.13	25.83	12.39	10.08
Long-Term Debt	25.91	26.78	0	0.92	0
Other Long-Term Liabilities	9.6	17.99	28.7	4.85	3.07
Total Long-Term Liabilities	35.51	44.77	28.7	5.77	3.07
Total Liabilities	63.81	72.89	54.53	18.16	13.15
Total Debt	27.11	27.75	0	1.58	0
Debt Growth	-2.30%	-	-	-	-
Retained Earnings	-299.29	-197.22	-97.79	-30.87	3.44
Comprehensive Income	0.03	-1.52	-0.14	0	0
Shareholders' Equity	368.4	300.87	387.83	-23.44	7.46
Net Cash / Debt	301.72	219.92	375.83	14.38	49.47
Net Cash / Debt Growth	37.20%	-41.49%	2514.48%	-70.94%	-
Net Cash Per Share	4.09	3.62	11.87	1.68	5.91
Working Capital	310.54	232.12	365.36	11.92	46.93
Book Value Per Share	4.99	4.95	12.25	-2.74	0.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).